PR

MEZOO, connecting health through technology
Sharing MEZOO’s technology and vision.
External
2026.11.09
Dong-A ST, MEZOO and Sungae Hospital Launch HiCardi-Based Smart Ward

On November 4, Dong-A ST, MEZOO and People and Technology held an opening ceremony for a smart ward built on the HiCardi wearable monitoring system at Sungae Hospital in Yeongdeungpo-gu, Seoul.

 

MEZOO supplies HiCardi and provides technical support. People and Technology connects the in-hospital medical devices with the hospital information system, and Dong-A ST coordinates the partners and supports operations. Sungae Hospital will use the system in clinical practice to strengthen ward patient care.

 

HiCardi is a patch-type wearable medical device attached to the chest. It continuously measures vital signs such as ECG and heart rate and sends them to a dedicated station. Monitoring continues while patients move around the ward, which helps staff notice changes in a patient's condition quickly and reduces repetitive vital-sign checks.

 

The ceremony was attended by Sungae Hospital Chairman Kim Seok-ho, Medical Center Director Jang Seok-il, Hospital Director Kim Young-jin, and MEZOO Executive Vice President Cho Sung-pil, among others.

 

Source : Pharmnews (Korean) https://www.pharmnews.com/news/articleView.html?idxno=307684

적용 법률 및 규정
의료기기

하이카디® 시스템은 인허가에 따라 신생아, 소아, 청소년, 18세 이상 환자의 ECG 데이터를 측정하여 부정맥을 진단하는 의료기기로서 의료전문가가 사용하도록 설계되었습니다. 한국 KFDA로부터 의료기기 2등급 인증을 받았습니다. 유럽의료기기 지침(2007/47/EC에 따라 개정된 MDD 93/42/EEC)에 따라 준수된 Class IIb (CE2265). 의료기기 제품으로 CE 승인되었습니다. 미국 FDA는 Class II 510K로 승인 완료 예정입니다.

경고

본 자료는 의료 전문가에게만 배포되며 관련 사진과 함께 제공되는 자료와 관련하여 그 어떤 법적인 책임을 갖지 않습니다. 사용 전 사용 지침서를 주의 깊게 읽으십시오.